A Phase 1, Open-Label, Two-Period, Fixed-Sequence, Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Oct 2016
Price : $35 *
At a glance
- Drugs Acebilustat (Primary)
- Indications Cystic fibrosis
- Focus Pharmacokinetics
- Sponsors Celtaxsys
- 28 Oct 2016 According to a Celtaxsys media release the result from this trial will be published in the journal Clinical and Translational Science (CTS), a publication of the American Society for Clinical Pharmacology and Therapeutics (ASCPT).
- 09 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Sep 2014 New trial record